Cumberland Pharmaceuticals

CPIX

Market cap $107M

CPIX Hedge Fund Activity: Q1 2026 in Review

29 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q1 2026, worth a combined $8.97M — down 24% from $11.8M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new CPIX positions and 6 closed out — a net gain of 3 holders — while 5 added to existing stakes and 9 trimmed.

The largest buyer was Marex Group, opening a new position worth an estimated $140K. The largest seller was Perceptive Advisors, cutting an estimated $555K.

• 29 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q1 2026, up from 27 in Q4 2025.
• Funds reported $8.97M of Cumberland Pharmaceuticals stock for Q1 2026, down 24% quarter-over-quarter.
• 9 funds opened new Cumberland Pharmaceuticals positions in Q1 2026 and 6 closed out, a net change of +3 holders.
• The largest Cumberland Pharmaceuticals buyer in Q1 2026 was Marex Group, an estimated $140K added.
• The largest Cumberland Pharmaceuticals seller in Q1 2026 was Perceptive Advisors, an estimated $555K sold.

Based on aggregated 13F filings for Q1 2026.